# Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles

> **Open Intelligence Dossier** · First detected: 2026-07-07 17:07 UTC · Category: Business

## Executive Summary
Vertex Pharma's $10 billion purchase of Crinetics sparks a near‑doubling of its shares and a biotech‑M&A surge

## Intelligence Brief
Vertex Pharma agreed to acquire Crinetics Pharmaceuticals for $10 billion, a deal highlighted across multiple business outlets. Coverage from Yahoo Finance, Barron's, The Boston Globe and others emphasizes the stock reaction—CRNX shares doubled, reached 52‑week highs, and a reported 99% surge.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Yahoo Finance | Viking Therapeutics (VKTX) Draws Takeover Focus After Vertex's $10 Billion Crinetics Deal | [Source Link](https://news.google.com/rss/articles/CBMiogFBVV95cUxPMWVZOUxhRERhTXladnd6VEhOd0Vuam9uTjFFS3ZUYW9WVlVkMHFFN1BZbXBOU052XzBRNThEUEhwRDNLSWNIVlQ5bHpHWm5SSUN1WFhoNkZWSnQweTU5WXhFU2R2bDMyWkxWQ3JYYUNra285QTJMUWxzeUlNT0lYXzlqbVJBd09FZ19CYm1XaW1VZFYxMDUyUUlBZExCSFBYTXc?oc=5) |
| Barron's | This Biotech Stock Is Soaring 99% After Vertex Agrees to Takeover Deal | [Source Link](https://news.google.com/rss/articles/CBMigwFBVV95cUxNeVdiY0NlWmE2cXVUd0Rhb1l3eW45cHZxYmNkZDJoNGtVcE1CVHRFNUtac2RoMVVlTGlQTEdfVlNya2ZkSmJpczl0QWk0V0F1bHBCQUtBTTBxenlZVzNveDAwSnZKSmhKOGJ2LWstQTBiN0hkUVlWS0JrVzRGRWUxd1g0VQ?oc=5) |
| The Boston Globe | Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A booms | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxPWlltX182S0tnVGlaRTVhQy1TbXdSQWJCeDNmUXNMeXBlQUNXcnF6SDRTSEt5SjhZb09IYzhEeHpsRy1xUUM5UXlwV05wYzlNTVdWajA2NlotT0JnSlZhc2lMeDdZNXdhakpjZXhRa0dlYWNoemloc2FUX2xYcFpXX1YzMTBJUGF2dXkyRDZraVVVT0Rx?oc=5) |
| Yahoo Finance | Why Did CRNX, D, BCRX Stocks Surge To 52-Week Highs Today? | [Source Link](https://news.google.com/rss/articles/CBMijAFBVV95cUxPc1VjZUhUR1pUOWlqY1l0UDZFcGhyMWhUYzBNbzNiNUw1a2xQdEI3NXF1VVVPaV9KbzhFaXRvY2xzaDFCYm52d0JhUC1pMEJFdUhhYWIwU05CWXVRbXZ5V0xaZXdvMURYWVM1OGJ5ZFJQSW1fZFRCQUx4dnpKNWl1bGY3MzZKLUlpcTVTUg?oc=5) |
| Yahoo Finance | VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout | [Source Link](https://news.google.com/rss/articles/CBMioAFBVV95cUxQbVpNTzA4SlBFRVVQU2gtU2J2SUpobDJ0dy1QWldIUU9qOUxDX1ltbnF0X0k4MkttbENpWFhxNHpKLVhoQTBvSHVZQTlsOW05N0VkZWQ5TnJfNEpFUUs2alk0OXhDVGd1UnN1SE43eEtqWjVqa2R6STBhYk5VWkNielIxc3E3YlhTSVZyVUhBOG0ySnlxc25qeTRYaml5SGYz?oc=5) |
| Endpoints News | Vertex's $10B Crinetics deal marks its clearest step yet toward biopharma's top ranks | [Source Link](https://news.google.com/rss/articles/CBMingFBVV95cUxNaWQtdFNGWFczT01GakViZmliaEt4NnVpcWNrR19Mc0xjaERLT1VBUTB2MzdVNWRuTkY1ZE9rZU5laGhBb1JsYWV1Q21kTm0zMFNaUlB6VFlhS0FHTDNQVXVOcXZvcFJYMEt0VVVESjNhaXNiVlhrd3pQRWxVWXpvTVNsaGJSd1pTOURpbUR0TExITzR4TThsMUl1dFpFQQ?oc=5) |
| BioPharma Dive | Vertex to acquire Crinetics in $10B foray into endocrine disease drugs | [Source Link](https://news.google.com/rss/articles/CBMimAFBVV95cUxObGtqX01EY3JxZkU3UFlPZnNvRlh4SDV6YlkyV19WbVBMZTA0aW9RZ1BqYlYxcTNCckxDVExDZFlabGhuNkc3aUNqNUZfS1BuVHpHcmxjeExlVDItekdkRFIwcEJ1X0ZaSV9tZlNiaDBtUGtIQktMME5WWGpsNVRmWUR2by11RDA0eUUxYk1KenBVRjdiZ1pTZA?oc=5) |
| Seeking Alpha | Biggest stock movers Tuesday: CRNX, RIVN, DOCN, and more | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxORTR0RkFPeGh4alhRbmhXV3VJMnhEMDVxM01QU21hVXpTLWp3N0VoV1FBaFN6d3hwWVRPOFJvT2tSNXVJemVkNDhVMC0taEN2QlBlNl9BYVBJNUJUejlhX3pxTDZhQTliQmlVODJKM1NjdlJvTmQwRG4tRFhIT29aX2xMcEl4cUhmX3I1b2Nn?oc=5) |
| Investor's Business Daily | Vertex Pharma Makes A $10 Billion Deal; Crinetics Stock Doubles | [Source Link](https://news.google.com/rss/articles/CBMilAFBVV95cUxQZ3IwMUlZd3prNXBXLVloTG5vTnRObXJUXzVQRDg5SHZnMlRJZWV3amprMHYtRmJNUWJRQXo2RkVHc2RjMGxoRFR6b2tlYmowSlRlbklEVm5XYlVGZjByZXRFNmgyWjR3blUzRVVqSEF3XzlxTUhfN0xEc3VQbFVLT213MngxY0YwOUxtXzNLNDRqa0Iz?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-07-07/vertex-pharma-makes-a-10-billion-deal-crinetics-stock-doubles*